ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $374,000 | +30.8% | 11,300 | +82.3% | 0.04% | +8.8% |
| Q1 2022 | $286,000 | -30.4% | 6,200 | +24.7% | 0.03% | -17.1% |
| Q2 2021 | $411,000 | +85.1% | 4,970 | +42.0% | 0.04% | +13.9% |
| Q4 2019 | $222,000 | -59.5% | 3,500 | -88.3% | 0.04% | -60.0% |
| Q1 2019 | $548,000 | +21.8% | 29,873 | -17.7% | 0.09% | +15.4% |
| Q4 2018 | $450,000 | +476.9% | 36,294 | +71.2% | 0.08% | +457.1% |
| Q4 2017 | $78,000 | – | 21,201 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |